This inventor holds 7 USPTO granted patents. Top assignee: Schering Corporation. Active years: 1976-1990.
Company Filing History:
Years Active: 1976-1990
Title: The Innovations of Rudolph O Neri
Introduction
Rudolph O Neri is a notable inventor based in Hawthorne, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of androgen-dependent diseases. With a total of 7 patents to his name, Neri's work has had a profound impact on therapeutic practices.
Latest Patents
Among his latest patents is a method of treating gynecomastia. This method is designed for noncastrated patients undergoing treatment with an antiandrogen for conditions such as benign prostatic hypertrophy. The treatment involves administering therapeutically effective amounts of an antiandrogen, such as flutamide, in conjunction with an antiestrogen like Tamoxifen or an aromatase inhibitor such as 4-hydroxyandrostenedione. Additionally, he has developed a pharmaceutical preparation comprising flutamide, which is useful in the treatment of prostatic carcinoma.
Career Highlights
Rudolph O Neri has had a distinguished career, working at Schering Corporation, where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in pharmaceutical treatments, particularly in oncology and endocrinology.
Collaborations
Throughout his career, Neri has collaborated with esteemed colleagues, including John G Topliss and Robert J Spiegel. These collaborations have further enhanced the quality and impact of his inventions.
Conclusion
Rudolph O Neri's contributions to medical innovation are noteworthy, particularly in the treatment of gynecomastia and prostatic carcinoma. His patents reflect a commitment to improving patient care through scientific advancement.